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Pulmonary cryptococcosis in a immunocompetent patient. 
A case report and a review 
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RESli~IO 
A Criptococosc e uma infec~iio relativamente 
rara causada por urn fungo, o Cripwcoccus neofor-
nrans, que se encontra largamente distribuido por 
todo o mundo. Apc)s a sua ina~o as manifesta~oes 
clinicas variam desde uma simples coloniza~o 
pulmonar ate uma infec~iio disseminada e invasiva. 
A maioria dos casos ocorre em doeotes imunodepri-
midos sendo a meningoencefalite a principal mani-
festa~ao da criptococose. 
ABSTRACT 
Cryptococcosis is a relatively rare infection, 
caused by the yeast-like fungus Cryptococcus neofor-
mans, an organism with a worldwide distribution. 
After the inhalation of Crypwcoccu.\· neofnrmans tbe 
clinical manifestations range from J)ulmonary 
colonization to disseminated invasive fungal infecti-
on. Most cases occur in immunocompromised 
patients and meningoencephalitis is the most com-
moo manifestation of cryptococcosis. 
lntcmo do lntcrnato Cotnplcmcntar de Pncumologaa do Centro Hospatal::rr Conde S Janunno 
Assastcnte Hospitalar Grndundo de Pncumologia do Centro Hospatnlar Conde S. Janu:ino 
Assastcntc Hospitalar Grnduado de Pneumologaa do Centro Hospatalar Conde S J anuano 
c Rcspons5Ycl do Sen u;o de Pneumolog•n do CHCSJ 
Recebido para publica~ao : 99.05.25 
Aceice para publka~iio: 99.07.09 
Julho/Agosto 1999 VoL V ·• 4 41 9 
REVIST A PORTUGUESA DE PNEUMOLOGIAICASO CLlNICO 
Os autores apresentam um caso de criptococose 
pulmonar num doente jovem e imunocompetente. 
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pun~ao aspirativa transtoracica. 
INTRODUCTION 
Cryptococcosis is a rare chronic, subacute to acute 
infection that causes three major fonns of disease: 
central nervous system (CNS), pulmonary, and 
disseminated infection. A truly cosmopolitan fungus, 
Clyptococcus neoformans, recognized to cause 
human infection on all five continents causes this 
disease. Ln contrast to other fungal diseases such as 
histoplasmosts and coccidioidomycosis, which are 
endemic in we11-defincd regions, cryptococcosis !s 
ubiquitous. 
Cryptococ.:us neo.formans, an encapsulated yeast, 
with vanable size and shape (round to oval) ( 1) was 
originally described as a human pathogen in 1894, as 
cited by Cameron and Perfect (2) and is classically 
a<>sociated with desiccated pigeon feces, although the 
orgamsm can be found in the feces (3) of other birds 
including turkeys and starlings as well as in bat feces. 
Soil often contains Ctyptococ.:cus, especially if is 
contaminated with bird droppings. 
Cryptococcosis is acquired by inhaling aerosols 
containing the yeast; it rarely occurs as a consequence 
of direct inoculation. Cryptococcus does not appear 
to spread directly from person to person (4). Once in 
the alveoli, propagation of the yeast begins by binary 
fission, and the organism reacquires its characteristi-
cally large polysaccharide capsule. Ctyplococ.:cus is 
unique among the pathogenic fungi in expressing an 
extensive polysaccharide capsule, which is primary 
detenninant of virulence m v1vo (s ). This capsule is 
strongly antipbagocytic, and its presence inhibits 
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We describe one case of pulmonary cryptococco-
sis in an immunocompetent young male patient. 
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chemotaxis. in many healthy individuals, there is a 
little celluJar response, and the organism grows as a 
mass of gelatinous material ; in others, abundant 
granuloma formation occurs, and the number of 
organism is small. The fungus produces no toxins, 
and there is very little tissue destruction. 
Although yeast can be isolated from the respira-
tory tract of immunocompetent hosts, C. neoformam 
is not considered normal respiratory nora in either 
humans or animals (6). 
Primary infection with Oyptococcus neoformans 
usually follows inhalation of the fungus with infecti-
on of the lungs. A transient colonization of the 
tracheobronchial tree may result, or more extensive 
pulmonary involvement may develop. Cryptococcal 
infection results in self-limited pulmonary disease in 
most healthy persons. Occasionally, isolated pulmo-
nary cryptococcosis is diagnosed (7). The final result 
of pulmonary cryptococcal infection may be a crypto-
coccoma or a residual pulmonary noduJe (8). 
After some time in the lungs, the organism hemato-
genously spreads to extrapuhnonary tissues; since it has 
a predilection for the CNS, infected persons usually 
contract meningoencephalitis (9), which is the most 
commonly recognized manifestation of cryptococcosis 
and the most common cause of death from cryptococcal 
mtection (10). The prostate, kidneys, lymph nodes, bone 
and skin may be involved in disseminated cryptococco-
sis, in fewer than 25% of cases_ 
This article reports the case of an immunocompe-
tent patient that presented a mass on chest radio-
graph, strongly suspicious to be malignant. 
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CASE REPORT 
A 38 year-old Chinese smoker (20 pack-years) 
male was sent in June 1996 to the outpatient Depart-
ment ofPulmonology of Centro Hospitalar Conde S. 
Januario because had an abnonnal chest radiograph. 
He had experienced dry cough and recurrent frontal 
pul5e-like headache with dizziness since March 
1996. He also reported a right chest pain for few days 
and a 3-4 kg weight loss. He denied dyspnea, he-
moptysis, fever, chills and night sweats. He had no 
h.istory of alcohol or drug use, HIV risk ractors and 
bad no known contact with an active tuberculosis 
patient. Social history was noncontributory. 
Several practitioners prescribed him a non-steroid 
anti-inflammatory that relieved the headache. After a 
chest radiograph, that showed an abnormal image, he 
was referred to our hospital. 
He had been employed as a blacksmith during 
several years. 
On physical examination his temperature, pulse, 
and respiratory rate were within nom1al ranges. Lung 
auscultation revealed slight decrease of breath sounds 
at the right posterior lower lung field. No lymphade-
nopathy was palpable and the neurologic examination 
showed no alterations. 
Laboratory studies were normal, except mild 
leukocytosis ( 13.300 cells/mm3 with 72% neutro-
phils), and increased erythrocyte sedimentation rate 
(81 mm/h). The HJVI and 2 serologic tests were 
negatives. 
The chest radiograph showed a well-demarcated 
mass in the right lower lobe with occlusion of the 
right costa-diaphragmatic angle. There was no hilar 
or mediastinal adenopathy (Fig.1 ). 
Computed tomography (CT) of the chest (Fig.2) 
showed a 5x 6-cm mass of heterogeneous density in 
the right lower lobe. A CT scan of abdomen and brain 
did not disclose any abnonnalities. 
The exammation with a bronchofiberscope revea-
led slight redness of the mucous on posterior basal 
segment of right lower lobe bronchus. The biopsy 
specimen of the mucous demonstrated inflammatory 
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Fig. I - Posteroanterior chest radiograph 
Fig. 2- CT scan of the chest 
signs. All cultures of the lavage fluid were negative 
and cytological examination of the lavage cell sho-
wed no evidence of malignancy. 
A percutaneous fine-needle aspiration was perfor-
med under fluoroscopic, and three specimens were 
obtained which showed an oval-shaped yeast, with 
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50J.1m diameter, that was uniformly positive with the 
Grocott methenamine silver (GMS) method (Fig.3) 
and strongly positive with mucincannine (Fig.4) 
suggestive of Cryptococcus neo.formans. 
The patient was treated with amphotericin B (0,3 
mg /kg/day), and 5-flucytosine (I OOmglkg/day) over 6 
weeks. He was switched to oral tluconazol (400mg 
daily) for three more weeks. The dimensions of the 
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Fig. 3- Fine-needle asptration showing an oval-shaped yeast. 
that was unifonnly positive with Grocott's methenan11ne 
silver nitrates (GMS) method staining 
Fig. 4- Mucicarmine stain showing densely staining cell wall 
and almost perfectly round shape, characteristic of 
CrypTococcus neoformans 
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mass markedly decreased (Fig.5) but the patient under-
went exc1sion ofthe mass because medical treatment 
could not completely eradicate the mfection. 
Fig. 5- CT scan of the chest after antifungal therapy 
DISCUSSION 
A rare disease before the HIV epidemic, crypto-
coccosis was identified very early in the epidemJc as 
one of the most common life-threatening infections 1n 
AIDS patient's ( 11). 
Although the prevalence of C. neo{orman.'i in 
pulmonary specimens is rare, the significance will 
depend mostly on the 1mmune status of the host, the 
viru lence of the C. neoformans, and the size of the 
moculum (12). The main morbidity tn cryptococcal 
mfectJOn comes from the dissemination of the fungus 
beyond the confines of the lung. 
C. neo/(mnans is strongly tropic for the CNS, and 
the vast majority of clinically recognized infections 
involve the meninges. 
Cryptococcal infection can affect people w1th 
mtact immune system, although it is diagnosed most 
often in persons with underlying immune defect (13) 
C'ryptoc:occus causes disease m immunocomproml-
sed hosts as well in apparently immunocompetent 
(14,15) like this case illustrates. 
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The predisposing conditions reflect the fact that T-
-celJ-mediated immunity IS the most tmponant 
mechamsm of defense against Cryptocor.:c:u., ( 16). 
Once a cenam amount of C!yptoc:oc:c:us ner~(ornum., 
is inhaJed it will fonn a polysaccharide capsule. The 
capsular polysaccharide has been sho"' n to interfere 
with the attachment of phagocytic cells to cryptococci 
and will induce T-cell suppresston of both the cell-
-mediated and antibody response to the organism. In 
most md1viduals, the symptoms are self-limited as 
polymorphonuclear leukocytes c-an ~ill the cryptococ-
ci before they capsulate. In the immunocompromised 
mdividuals, the organism in the lung will cause a 
mild inflammatory response. In this patient we do not 
found any predisposmg factors to the cryptococcal 
infection 
Approximately 80 to 90% of cases of cryptococco-
sis are identilied Ln hosts with advanced 1 IIV infecti-
on (17,18). 
Other well-described causes of immunosuppressi-
on mclude long-standing 1mmunosupressive treat-
ment regimens, organ transplantation, Hodgkin· sand 
non-Hodgkin's lymphoma, leukemia, diabetes mellt-
tus, and ltver disease such as Cirrhosis (12). The 
infectton there appears 10 be no race-related predilec-
tion but has been diagnosed m two to three times as 
many males as females and typically occurs in adults 
(4). The fungus demonstrates no endem1c pattern of 
distribuuon (19). 
Temperate climates are the primary location for 
this encapsulates fungus that 1s believed to lead to 
cryptococcosis followmg inhaJation of the organ1sm 
(20). Pulmonary mfection can be asymptomatic and 
subclimcal, mild and self-limited. or severe and 
progressive ( 4). The majority of pauents w1th clinical 
symptoms are immunocomprom1sed (2.4) In immu-
nocompetent patients, cryptococc.al infecuons usually 
are lim1ted to the lung: disseminated disease IS rare 
(2.4). Pnmary pulmonary cryptococcosis was lirst 
reviewed by Campbell in 1996 (21) In this case 
series. only 20% had posit1ve sputum culture Appro-
ximately one-third of hosts are asymptomatic, while 
the other two-thirds present with symptoms such as 
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cough, chest pam, sputum production, fever, we1ght 
loss, and hemoptysis. 
ln another series (22) mdividuals nonimmunocom-
prornised with the pulmonary fonn developed 
symptoms in about one-half of the cases while the 
remaming patients were discovered to have crypto-
coccosis onJy after evaluation of an abnonnallt) 
discovered on routme chest radiographic exammah-
on. Cough, mild sputum production, and low-grade 
fever may be the only mani testation of initial exposu-
re to C. neoformans 
In contrast to nonimmunocompromised patients, 
most patients with AIDS and pulmonary cryptococco-
SIS have symptoms of fever and cough (23) lmmunos-
supressed patients with pulmonary cryptococcos1s 
commonJy (Ill about 80% of cases) develop meningo-
encephalitis (7). 
Radiographic manifestations of pulmonary infecti-
on ranges widely and depend on both the immune 
status and type of C. neoformans. WeU-def~ned 
nodular (single or multiple) mfiltrates or well-defined 
patchy infiltrates are commonly seen rn the nonnal 
host (22). Diffuse pulmonary d1sease assoctated w1th 
diffuse interstitial infiltrates, or widespread alveolar 
consolidation is more commonly seen in AIDS 
patients or in those who are severely tmmunodeftcl-
ent (24.25). Mass lesions, as seen in our patient, are 
not uncommon and may resemble malignancy. 
Pleural effusion is rare. CavitatiOn is uncommon, and 
mediastinal adenopathy, pleural effusiOn, and calcifi-
cation are rare Empyema, pneumothorax and pleural 
mvolvement suggesting a Pancoast's tumor have 
been reponed (26,27,28). Miliary pattern rn a patient 
with the AIDS was described by Douketis (29). 
Diagnosis of cryptococcal pulmonary infection 
requires isolation of the organism from pulmonary 
secretions or tissues or visualization in histopatholo-
gic specimen (30). Sputum cultures are unreliable for 
establishing the diagnosiS because C. neo(ormam 
can colonize Lhe upper a1rway ofuninfected pauents. 
and cultures may be negative even with an acuve 
infection (3). The diagnosis by fine needle aspiration, 
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has· been previOusly described (31 ), may be necessary 
to confinn the diagnosis of pulmonary infection. The 
d1agnostic yield of fine needle aspiration, in cases 
hke our patient, bas been shown to be higher than 
that of bronchoscope w1th b1opsy (32) 
Cryptococci may be d1fficult to visualize on 
routine hematoxylin-and-eosm-stained sections, 
although identification of the organism can be enhan-
ced by use of appropriate special stain (Jo). The 
diagnosis is based on the strongly positive Mayer's 
mucicarmine, Grocott's Methenamine Silver or 
Perodic acid-Scbiff stammg of the organ1sm m the 
tissue (33). Increased cryptococcal antigen tJters ( 1·8 
or more) are indicative of high burden of orgamsm m 
the lung or of dissemmated infection or both (2). 
Direct cryptococcal antigen detenninations on lung 
aspirates (34), brochoalveolar fluid (35), pleural 
effusion (36), serum (37). have also previously been 
utllized rn the diagnosis of pulmonary cryptococcosis. 
In a recent review (38) Aberg and colleagues conclu-
ded that in the maJority of the patients with pulmo-
nary cryptococcosis who arc not IIIV-infected. the 
lung appeared to be the sole organ involved, and a 
workup for systemic infection was rarely helpful. 
As the treatment of pulmonary cryptococcosis has 
not been the subject of extensive study, recommenda-
tions regarding therapy for this fonn of cryptococcal 
infection must be inferred from treatment regimens 
used for meningitis (30). Patz et al (39) and Kerkring 
( 40) suggest that isolated pulmonary rnfectlons m 
Immunocompetent pattents does not reqUire antifun-
gal therapy. Arnphotericm B and Flucytosine for at 
least 6 weeks have been considered standard for 
patients without HlV infection. Beyond medical 
management surgical treatment is considered in those 
patients with localized d 1sease ( 41) and/or has no 
response to medical treatment. 
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